ZYME ▼ -0.3% - Zymeworks Inc. $ZYME - Zymeworks Completes Acquisition of Theravance Biopharma Zymeworks shares fell 0.3% following the company's completion of its acquisition of Theravance Biopharma. The deal expands Zymeworks' pipeline and combines the two companies' biopharmaceutical programs. 23-SEP-2026 04:01 PM ET